Want to join the conversation?
$URI now expects 2016 rental rates and adjusted EBITDA to track toward the upper end of previous guidance and free cash flow to exceed its prior expectations. This takes into account $URI's plan to invest up to additional $50MM in fleet to service specific large contract wins.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.